Literature DB >> 8019291

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.

G K Wilcock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8019291      PMCID： PMC2540310     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Tetrahydroaminoacridine and Alzheimer's disease.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1994-04-02

2.  Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.

Authors:  N Maltby; G A Broe; H Creasey; A F Jorm; H Christensen; W S Brooks
Journal:  BMJ       Date:  1994-04-02

3.  An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

Authors:  G K Wilcock; D J Surmon; M Scott; M Boyle; K Mulligan; K A Neubauer; D O'Neill; V H Royston
Journal:  Age Ageing       Date:  1993-09       Impact factor: 10.668

4.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

Authors:  M Farlow; S I Gracon; L A Hershey; K W Lewis; C H Sadowsky; J Dolan-Ureno
Journal:  JAMA       Date:  1992-11-11       Impact factor: 56.272

5.  A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

Authors:  M J Knapp; D S Knopman; P R Solomon; W W Pendlebury; C S Davis; S I Gracon
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.